Trek Financial LLC Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Trek Financial LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 77.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,952 shares of the biotechnology company's stock after selling 10,318 shares during the quarter. Trek Financial LLC's holdings in Axon Enterprise were worth $1,754,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Asset Dedication LLC lifted its holdings in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares during the period. Bleakley Financial Group LLC lifted its stake in shares of Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC boosted its position in shares of Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after purchasing an additional 21 shares in the last quarter. Insigneo Advisory Services LLC grew its stake in Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after purchasing an additional 22 shares during the period. Finally, Burns Matteson Capital Management LLC increased its holdings in Axon Enterprise by 3.4% in the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company's stock worth $450,000 after purchasing an additional 25 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Remove Ads

Axon Enterprise Stock Up 3.0 %

AXON traded up $16.73 during midday trading on Friday, reaching $567.98. 516,424 shares of the company were exchanged, compared to its average volume of 815,515. The company has a market cap of $43.52 billion, a price-to-earnings ratio of 146.77, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company's fifty day moving average price is $567.07 and its 200 day moving average price is $560.54. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 6.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on AXON shares. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Needham & Company LLC reissued a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $626.45.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.